PMID- 21924080 OWN - NLM STAT- MEDLINE DCOM- 20120702 LR - 20110919 IS - 0253-3758 (Print) IS - 0253-3758 (Linking) VI - 39 IP - 6 DP - 2011 Jun TI - [Tumor necrosis factor-alpha promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway]. PG - 531-7 AB - OBJECTIVE: Tumor necrosis factor-alpha (TNF-alpha) is known to induce changes in endothelial cell morphology and permeability. The aim of this study is to determine the underlying signaling mechanisms involved in these responses. METHODS: Cultured human umbilical vein endothelial cells (HUVECs) were exposed to TNF-alpha, and HUVEC cytoskeletal changes were evaluated by observing fluorescence of F-actin following ligation with labeled antibodies. Endothelial permeability was detected by measuring the flux of horseradish peroxidase (HRP)-albumin across the EC monolayers. To explore the signaling pathways behind TNF-alpha-induced changes in HUVEC morphology and permeability, HUVECs were treated with either the Rho GTPase inhibitor Y27632 or the mitogen-activated protein kinases (MAPK) inhibitors PD98059 and SB203580 before TNF-alpha administration. To further elucidate possible involvement of the RhoA and ERK pathways in TNF-alpha-induced HUVEC changes, retrovirus-carried recombinant dominant-negative forms and constitutive-activative forms of RhoA, namely T19NRhoA and Q63LRhoA, were pre-infected into HUVECs prior to TNF-alpha exposure. RESULTS: TNF-alpha induced F-actin cytoskeleton rearrangement and increased HUVEC permeability in a dose and time-dependent manner. The maximal increase in the HRP-BSA flux (40 ng/ml) was seen in cells exposed to TNF-alpha at 100 ng/ml after 2 h. Preconditioning of HUVEC monolayer with Y27632 or PD98059 significantly reduced TNF-alpha induced permeability increase (HRP concentration from 40 ng/ml decreased to 12.5 ng/ml, P < 0.05) and F-actin cytoskeleton rearrangement, HUVEC pre-infection with activated forms of Q63LRhoA increased HUVEC permeability and upregulated pERK compared to GFP infection, while HUVEC pre-infection with inhibited forms of T19NRhoA attenuated the effects of TNF-alpha on HUVEC permeability. CONCLUSION: These results indicate that TNF-alpha-induced EC barrier dysfunction and morphological changes of the F-actin via activating RhoA-ERK/MAPK signal pathway. FAU - Yan, Cheng-Hui AU - Yan CH AD - Department of Cardiology, Shenyang General Hospital, Shenyang 110840, China. FAU - Yu, Hai-Bo AU - Yu HB FAU - Huang, Ming-Fang AU - Huang MF FAU - Li, Jie AU - Li J FAU - Zhang, Xiao-Lin AU - Zhang XL FAU - Han, Ya-Ling AU - Han YL LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Xin Xue Guan Bing Za Zhi JT - Zhonghua xin xue guan bing za zhi JID - 7910682 RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 3.6.5.2 (rhoA GTP-Binding Protein) SB - IM MH - *Cell Membrane Permeability MH - Cells, Cultured MH - Cytoskeleton/*metabolism MH - Endothelial Cells/cytology/drug effects/metabolism MH - Endothelium, Vascular/cytology MH - Human Umbilical Vein Endothelial Cells/drug effects MH - Humans MH - Mitogen-Activated Protein Kinases/*metabolism MH - Signal Transduction MH - Tumor Necrosis Factor-alpha/*pharmacology MH - rhoA GTP-Binding Protein/*metabolism EDAT- 2011/09/20 06:00 MHDA- 2012/07/03 06:00 CRDT- 2011/09/20 06:00 PHST- 2011/09/20 06:00 [entrez] PHST- 2011/09/20 06:00 [pubmed] PHST- 2012/07/03 06:00 [medline] PST - ppublish SO - Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jun;39(6):531-7.